trial · primary record
JNJ-78278343
Prostatic Neoplasms
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 355 |
| Primary completion | 2028-06-28 |
| Primary endpoint | Parts 1, 2C, 3 and 4: Number of Participants With Dose Limiting Toxicity (DLT) |
| Registry ID | NCT06095089 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:29.952Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06095089
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Jnj-78278343 · compound